Inotiv (NOTV) 10-K2005 FY Annual report

Filed: 18 Jan 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	7th grade Avg

New words: advisor, antidilutive, appeal, appetite, APS, awaiting, buying, calculation, cancer, causal, cease, cell, Chait, counted, decided, doubtful, DuPont, earlier, Edward, employment, enacted, enactment, energy, expend, expressing, fall, genetic, hand, identification, influenced, Insider, issuable, lending, load, molecular, pace, payee, PharmaCore, PositionPeter, profile, pronouncement, purpose, Qualitative, Quantitative, redirected, reorganized, revalidating, reverse, settled, Spectral, strongly, Supplementary, temporary, transition, turnaround, turned, unable, volume

Removed: ABS, addressing, adversely, affected, awarded, Biology, Charleston, combined, dated, Doctor, Eli, event, Inspire, leasing, Leigh, Lilly, LLP, miniaturizedin, modified, operational, parent, plasma, Profound, promissory, recently, Reserve, rodent, sampler, society, tactical, theculex, Thompson, unaudited, unrelated, urine, Western

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

NOTV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

I, Peter T. Kissinger, the Chairman of the Board; President; and Chief Executive Officer of Bioanalytical Systems, Inc., certify that (i) the Annual Report on Form 10-K for the year ended September 30, 2005, (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bioanalytical Systems, Inc. as of the dates and for the periods set forth therein.

/s/ Peter T. Kissinger

Peter T. Kissinger
Chairman of the Board
President and Chief Executive Officer
January 12, 2006

I, Michael R. Cox, Vice President, Finance, Chief Financial Officer and Treasurer of Bioanalytical Systems, Inc., certify that (i) the Annual Report on Form 10-K for the year ended September 30, 2005, (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bioanalytical Systems, Inc. as of the dates and for the periods set forth therein.

/s/ Michael R. Cox

Michael R. Cox
Vice President, Finance, Chief Financial
Officer and Treasurer
January 12, 2006

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.